Let’s Talk About Vitamin K for Newborns – by Dr. Nicole Betancourt, Pediatrician

The first hours after birth are a period of remarkable transition, but they are also a time when newborns face unique physiological vulnerabilities. One of the most important - and often underappreciated - preventive interventions in newborn care is the administration of vitamin K shortly after birth.

Because newborns are naturally born with very low stores of vitamin K, they are at risk of developing vitamin K deficiency bleeding (VKDB), a potentially life-threatening condition that can cause severe internal bleeding, including bleeding in the brain. A single dose of vitamin K given at birth has been shown to dramatically reduce this risk, making it a simple, safe, and highly effective measure that helps protect infants during their earliest and most vulnerable days of life.

The Rise of Vitamin K Prophylaxis Uncertainty

There is a growing need to discuss vitamin K administration in newborns because, despite decades of evidence supporting its safety and effectiveness, there is a surge of uncertainty about newborn care practices, including vitamin K prophylaxis. Prophylaxis is when medical action is taken to prevent the onset of disease or preserve a person’s health. It’s preventive care, meant to stop a possible illness or condition from occurring in the first place rather than treating it once in progress.

The rise of health information—and misinformation—on social media and online platforms has largely contributed to the decline of its administration. At the same time, healthcare providers continue to encounter cases of vitamin K deficiency bleeding, a rare but potentially devastating condition that is largely preventable with a single dose of vitamin K given shortly after birth. As more families seek to make informed decisions about their child's care, open, evidence-based conversations about the purpose, benefits, and safety of vitamin K administration have become essential.

These discussions help ensure that parents understand both the risks of vitamin K deficiency and the critical role this simple intervention plays in protecting newborns from serious bleeding complications and potential risk of death – so let’s talk about it!

What is Vitamin K?

Vitamin K is a fat-soluble vitamin that plays an essential role in the body's ability to form blood clots and prevent excessive bleeding. Vitamin K helps the liver produce several clotting factors—proteins that work together to stop bleeding when blood vessels are injured. It is also important for bone health and the regulation of calcium within the body.

There are two main forms of vitamin K: Vitamin K1 (phylloquinone) is found primarily in green leafy vegetables such as spinach, kale, and broccoli. Vitamin K2 (menaquinone) is produced by certain bacteria in the gut and found in some animal products and fermented foods.

Newborns are naturally born with very low levels of vitamin K because only small amounts cross the placenta during pregnancy. Their intestines have not yet developed the bacteria that can produce vitamin K and breast milk contains relatively low amounts of the vitamin. As a result, newborns are at increased risk for VKDB, a condition in which bleeding can occur spontaneously or after even minor trauma. This can be serious and sometimes life-threatening. For this reason, healthcare organizations around the world (including the international World Health Organization, the U.S. Centers for Disease Control and Prevention, and the New York State Department of Health) recommend administering vitamin K shortly after birth to help ensure that infants have adequate levels to support normal blood clotting during the first months of life.

Why does Vitamin K deficiency put a baby at risk?

Vitamin K deficiency can have serious consequences for newborns because it impairs the body's ability to form blood clots.

Potential risks of vitamin K deficiency include: 

• Bleeding from the umbilical cord stump or circumcision site that is difficult to stop
• Bruising easily, even with minimal pressure or handling
• Bleeding in the gastrointestinal tract, which may appear as blood in the stool or vomit
• Nosebleeds or bleeding from the mouth
• Internal bleeding, which may not be immediately visible and can become severe before it is detected 
• Intracranial hemorrhage, otherwise known as bleeding in the brain, one of the most serious complications. This can lead to seizures, brain injury, developmental delays, neurological disabilities or death.
   

VKDB is classified as early, classic, or late.  Early VKDB occurs within the first 24 hours after birth. It is often associated with certain maternal medications. Classic VKDB typically occurs between days 2 and 7 of life. Late VKDB occurs between 2 weeks and 6 months of age, most commonly in exclusively breastfed infants who did not receive vitamin K at birth. Late VKDB frequently presents with brain bleeding and may occur without warning signs.

The challenge is that many babies with vitamin K deficiency appear completely healthy until a bleeding episode occurs. Because VKDB can develop suddenly and have devastating consequences, a single vitamin K dose given shortly after birth is considered one of the most effective preventive measures in newborn care.

How Common is Vitamin K Deficiency Bleeding?

The frequency of VKDB depends largely on whether a baby receives vitamin K at birth.

Without vitamin K prophylaxis, early and classic VKDB occur in about 1 in 400 to 1 in 60 newborns. Infants who do not receive the vitamin K injection are estimated to have an 81-fold higher risk of developing late VKDB compared with those who receive prophylaxis. Of these infants presenting with late VKDB, upwards of 60% present with a brain bleed, which can result in permanent neurologic injury, developmental disabilities, or death.

Vitamin K in Breast Milk vs. Formula

The amount of vitamin K available to an infant differs significantly between breast milk and infant formula. Human breast milk contains relatively low concentrations of vitamin K. Even in healthy, well-nourished parents who are breastfeeding, the amount of vitamin K transferred through breast milk is generally insufficient to reliably protect infants from vitamin K deficiency during the first months of life. As a result, exclusively breastfed infants who do not receive vitamin K prophylaxis at birth are at the highest risk for VKDB, particularly the late form that can occur between 2 weeks and 6 months of age.

Infant formulas are fortified with vitamin K and typically contain substantially higher amounts than breast milk. Formula-fed infants therefore receive a more consistent dietary source of vitamin K during infancy. While formula feeding does not eliminate all risk of VKDB in newborns who did not receive prophylaxis, it is associated with a lower risk of late VKDB compared with exclusive breastfeeding.

Even though formula contains more vitamin K than breast milk, all newborns—whether breastfed, formula-fed, or combination-fed—are born with very low vitamin K stores. The vitamin K injection given shortly after birth provides immediate protection during this vulnerable period, before feeding alone can reliably supply adequate amounts.

The lower vitamin K content of breast milk is not a flaw in breastfeeding. Human milk is uniquely adapted to meet an infant's other nutritional and immunological needs.

Vitamin K in Preterm Infants

Preterm infants, those delivered weeks before their due date, can be particularly vulnerable to vitamin K deficiency and its complications. Like all newborns, preterm babies are born with limited vitamin K stores, but their risk is often even greater because they have had less time in the womb to accumulate nutrients. Only small amounts of vitamin K cross the placenta during pregnancy.

These infants’ livers may also be immature, they may have delayed or limited feeding, and their intestinal gut flora may remain even more immature than an infant delivered at term. Preterm infants also often need more medical interventions and even procedures. All of this can greatly impact their risk of a serious or potentially catastrophic bleed.

How Do We Prevent VKDB in Newborns?

The most effective treatment for VKDB is prevention. A single intramuscular (IM) vitamin K injection given shortly after birth rapidly fills up vitamin K stores and provides protection against VKDB during the first months of life.

One of the most common questions parents ask is whether vitamin K should be given as an injection or by mouth. While both approaches aim to prevent vitamin K deficiency, they are not equally effective. In many countries, including the United States, the recommended regimen is 1 mg of vitamin K1 (phytonadione) administered intramuscularly (IM), by injection, shortly after birth for term infants. Smaller doses may be used for very low birth weight or extremely preterm infants according to institutional protocols. The injection is typically given into the infant's thigh within the first few hours after birth.

The IM injection has several advantages: 

• One-time administration 
• Reliable absorption that is not dependent on feeding patterns or intestinal uptake

While oral vitamin K may be an option in some countries, it requires strict adherence to multiple doses and is generally less effective at preventing late VKDB, the form most likely to cause life-threatening brain hemorrhage. In the United States, there is no FDA- approved vitamin K oral supplement for infants.

Circumcisions and Vitamin K

Circumcision is generally a safe procedure when normal clotting mechanisms are in place. Because newborns begin life with very low vitamin K levels, administering vitamin K before circumcision helps ensure that infants can form stable blood clots and recover safely from the procedure, while also providing broader protection against potentially serious bleeding complications.

Healthcare providers generally recommend that newborns receive vitamin K before undergoing circumcision because it significantly reduces the risk of procedural bleeding, helps ensure normal clotting function during and after the procedure, provides protection against unrecognized vitamin K deficiency that may not be apparent on physical examination, and decreases the likelihood of the infant requiring additional medical intervention for bleeding complications.

Although serious bleeding after circumcision is uncommon, vitamin K deficiency can increase both the frequency and severity of bleeding events.

Let’s Talk About It

A healthy delivery does not remove the need for the vitamin K birth dose. It provides your baby with a much-needed boost to their levels of a critically important vitamin, needed to prevent bleeding that can be potentially deadly. In medicine, we like to prevent conditions before they happen whenever possible and I’m sure parents would agree. We all want to put an infant on the path for a healthy life.

The injection is not a vaccine and it contains no harmful synthetic preservatives. If you are a soon-to-be-parent and you have questions or concerns, bring them to your next appointment. We are happy to have a conversation with you, without judgment. 

About the Author
Nicole Betancourt, MD, is a pediatric hospitalist at Bassett Medical Center and the Bassett Birthing Center in Cooperstown. She has been providing care to newborn babies and children admitted to the hospital for over 14 years. Dr. Betancourt completed her medical degree at Albany Medical College, residency at Albany Medical Center, and fellowship in pediatric critical care medicine at St. Christopher's Hospital for Children in Philadelphia, PA. She is board-certified by the American Board of Pediatrics.